0001127602-23-012013.txt : 20230404 0001127602-23-012013.hdr.sgml : 20230404 20230404063053 ACCESSION NUMBER: 0001127602-23-012013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230404 DATE AS OF CHANGE: 20230404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Theagene Jean-Manasse CENTRAL INDEX KEY: 0001969857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 23795043 MAIL ADDRESS: STREET 1: 500 PLACE D ARMES STREET 2: SUITE 1800 CITY: MONTREAL STATE: A8 ZIP: H2Y 2W2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-03-31 0001878313 MAIA Biotechnology, Inc. MAIA 0001969857 Theagene Jean-Manasse 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 1 0 Stock Options 3.46 2023-03-31 4 A 0 945 0 A 2023-03-31 2033-03-31 Common Stock 945 945 D The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. /s/ Jean-Manasse Theagene 2023-04-04